Aurobindo Pharma USA, Inc. is a generic pharmaceutical manufacturer and distributor and is a wholly owned subsidiary of Aurobindo Pharma Limited, a leading generic pharmaceutical company based in India. Headquartered in HITEC City, Hyderabad, India, founded in 1986 and becoming a public company in India in 1992.
Aurobindo Pharma USA, Inc. is committed to delivering a broad portfolio of quality, affordable generic pharmaceuticals to pharmacists and patients. Aurobindo Pharma USA, Inc. adds value through superior customer service in the distribution of a broad line of generic pharmaceuticals, leveraging vertical integration and efficient controlled processes. Aurobindo has business operations in more than 125 countries around the world. Aurobindo is a global pharmaceutical company with a broad portfolio of generic drugs that includes more than 180 product families and 450 individual product packages.
3rd largest pharmaceutical company in the US by volume
Fastest growth rate among Top 10 pharmaceutical companies
Over 180 actively marketed product families
Once Acquisition Closes:
2nd Largest Company in terms of volume
Over 400 product families actively marketed
Over 100 non-marketed ANDA’s ready for relaunch
Over 220 ANDA’s pending approval, market value in excess of $80B
Over 40 Product Launches planned for current fiscal year
Nearly 1 in 10 scripts dispensed will be an Aurobindo generic product